🔎 Trials Near Me

Beranda › Osteosarkoma › New Jersey

Uji klinis Osteosarkoma di New Jersey

6 studi untuk Osteosarkoma mencari peserta di lokasi di New Jersey.

Kota di New Jersey

Teks studi resmi (Bahasa Inggris)

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

  • Hackensack University Medical Center, Hackensack
Menerima pesertaFase 1/2
Hingga usia 26 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06465199

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

  • Hackensack University Medical Center, Hackensack
Menerima pesertaFase 1/2
Hingga usia 30 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06541262

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

  • Hackensack University Medical Center, Hackensack
  • Morristown Medical Center, Morristown
  • Saint Peter's University Hospital, New Brunswick
  • dan 2 lainnya
Menerima pesertaFase 3
Hingga usia 50 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT05235165

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

  • Hackensack University Medical Center, Hackensack
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 18 Mei 2026 · NCT01790152

Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas

  • Memorial Sloan Kettering at Basking Ridge (Consent and Follow Up), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Consent and Followup), Middletown
Menerima pesertaStudi observasional
Usia 4 ke atas · Semua jenis kelamin · Diperbarui 17 Apr 2026 · NCT03442465

A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma

  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering at Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering at Bergen (Limited Protocol Activities), Montvale
Menerima pesertaFase 2
Usia 6 hingga 49 · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT07477457

Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.